| abstract |
The present disclosure relates to ureteral stents, and in particular, compositions for ureteral stents used to ensure patency of the ureters, i.e., urethral stones, passages that can be damaged by neoplasia or surgical procedures. About. The solution of the present disclosure relates to compositions for biodegradable stents, and more particularly to ureteral stents and methods for obtaining such stents. This disclosure overcomes the problems faced with available stents, particularly ureteral stents; that is; avoids the need for a second surgery for stent removal; reduces the morbidity of patients undergoing surgery Reduce or eliminate the risk of infection after ureteral stent implantation. |